As a kinase inhibitor of multiple targets, it is capable of blocking tumor cell multiplication via restraining the activation of Raf-1, B-RAF and kinases in Ras/Raf/MEK/ERK pathway. This evidence concerns the gene RAF1 and neoplasm.